We are monitoring the impact of COVID-19 on Protein Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5061
Share on
Share on

Global Protein Therapeutics Market Size, Share, Trends, COVID-19 impact & Growth Analysis Report – Segmented By Product, Application, Therapeutic Modalities & Region - Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 5061
Pages: 175

Global Protein Therapeutics Market Size (2020 to 2025)

The size of the global protein therapeutics market was around USD 159.93 billion in 2020. It is expected to grow at a CAGR of 6.5% to reach USD 219.12 billion by 2025.

Protein therapeutics are most often employed in the treatment of chronic ailments like cancer etc. This market has enormous potential in the coming years.

MARKET DRIVERS:

The growth of the global protein therapeutics market is primarily driven by the factors such as increasing demand for protein therapeutics, increasing prevalence of chronic diseases, and the development of plasma-derived therapies that are promoting the market growth. Furthermore, creating awareness among the population regarding protein therapeutics can influence market growth. Increasing incidences of chronic diseases such as cancer, cardiovascular conditions, and diabetes are expected to drive market growth during the forecast period. High efficiency of therapeutics with minimum risk of side effects increases the acceptance among the end-users.

Additionally, the global protein therapeutics market is supported by the rapid rise in technological advancements, wide usage of MABs (monoclonal antibodies) to treat several diseases. Many FDA approvals such as Trastuzumab, Ranibizumab, Rituximab, Panitumumab, Ofatumumab, Pembrolizumab, Alemtuzumab, Cetuximab, ipilimumab, and Gemtuzumab ozogamicin are now available. Moreover, the global protein therapeutics market is further accelerated by the rising awareness about protein therapeutics, rapid growth in the adaption of plasma-derived therapies to manage chronic disorders by encouragement. Additionally, many initiatives were taken by the various governments to develop the healthcare sector by providing favorable conditions to contribute a significant boost to the global protein therapeutics market.

MARKET RESTRAINTS:

Significant restraints for the global protein therapeutics market are high expenditure of protein therapies, strict and harsh to the regulatory framework which are related to approval of the product. These factors are major restraints of the protein therapeutics market.

Additionally, the high cost for installing and maintaining the devices in laboratories and stringent government regulations towards protein therapeutics are restricting the market growth of the protein therapeutics market. Physiochemical instability of proteins and immunogenicity are majorly restricting the global protein therapeutics market over the forecast period. Stringent regulations related to product approval are expected to propel the market growth.

Impact of COVID-19 on the global protein therapeutics market:

COVID-19 pandemic outbreak affected every market adversely. After the WHO's declaration (World Health Organization), every country in the world self-declared the lockdown to maintain social distance. This spam of time affected every market in numerous ways, such as limitation, disruption, modifications, and challenges. As same as COVID-19 also impacts the protein therapeutics market. The protein therapeutics market has a negative impact due to the COVID-19 pandemic. The major challenge is the limitation of availability for conditions of medical care rather than COVID-19. Limitation in the availability of healthcare staff over the world is also a factor with negativity. Patients suffering from lacking hormones will face the most difficulties due to the urgent requirement of treatment. However, surgeries will be postponed that are negatively impacting the protein therapeutics market.

Due to lockdown restrictions everywhere globally during the first half of 2020, the protein therapeutics market has seen a downfall. But with the increasing prevalence of developing a vaccine or drug to treat the deadly coronavirus disease using protein therapeutics, the growth rate is growing eventually. Scientists are in a race to develop an effective vaccine without causing any side effects to the people.  Also, increasing awareness over the importance of protein management to stay healthy is greatly influencing the growth rate of this market.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Product, Application, Therapeutic Modalities, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Baxter International Inc., Eli Lilly, and Company, Abbott Laboratories, Amgen Inc., F. Hoffmann-La Roche Ltd. Other players in the market are Novo Nordisk A/S, Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., and Sanofi.

 

This market research report on the global protein therapeutics market has been segmented and sub-segmented based on the product, application, therapeutic modalities, and region.

Protein Therapeutics Market - By Product:

  • Monoclonal Antibodies
  • Insulin
  • Fusion Protein
  • Erythropoietin
  • Interferon
  • Human Growth Hormone
  • Follicle Stimulating Hormone

Based on the product, in 2019, Monoclonal antibodies captured the largest market share. It is projected to remain the top leading segment in the forecast period. It is also the market sub-segment, which is anticipated to undergo the fastest growth by 2025.

Monoclonal antibodies are extracted or developed from a similar parent immune cell for recognizing or targeting specific cells. Those antigens will behave as antibodies in tandem with the human immune system against them. Monoclonal Antibodies will be used for treating complications cases in medical about substance cancer, viral infection, poisoning, septicemia, abuse, and asthma. This segment is accounting for fast growth by product segment.

The crucial and primary hormone in our body is Insulin. Insulin hormone plays a vital in controlling levels of blood glucose. People with diabetes are due to a shortage of insulin levels in the blood. Insulin plays a crucial role in the management of diabetics and can lead to complications. The insulin segment is also contributing a large share in the protein therapeutics market.

Wide range of usage to treat cancer by the fusion protein. Two different genes manufacture fusion proteins. This segment is a contributing share in the protein therapeutics market.

Erythropoietin will promote the formation of red blood cells produced by the kidney through the bone marrow. Erythropoietin segment is also attributing share.  

Interferon is used to treat multiple sclerosis (MS), several cancer forms, and hepatitis C due to synthesized by a signaling group. It is released by the host cell in response to protect against several viruses.

A small protein formed in the pituitary gland by secreting within the bloodstream is a human growth hormone. Production of human growth hormone will help control complex hormones in the hypothalamus of the brain and intestinal tract, and pancreas.

The pituitary gland produces Follicle-stimulating hormone, and it is an essential hormone for normal functions of reproduction systems in both genders. This segment is also attributing the largest share in the protein therapeutics market.

Protein Therapeutics Market - By Application:

  • Metabolic Disorders
  • Immunologic Disorders
  • Hematological Disorders
  • Cancer
  • Hormonal Disorders
  • Genetic Disorders
  • Others

Based on the application, in 2019, metabolic disorders accounted for the highest market share. However, the cancer market sub-category is predicted to grow the fastest in the forecast period.

Among all these segments, the cancer segment contributes the largest share by recording a high compound annual growth rate over the forecast period. The cancer segment is owning many advantageous factors, such as a rise in cancer prevalence leads to an increase in demand for the protein therapeutics market. As per the International Agency for Research on cancer, nearly 1,80,78,957 cancer cases are detected worldwide. Expecting these factors are drivers of the cancer segment.

Metabolic disorders are related to the pancreas or liver in the body due to the increment in the prevalence of metabolic disorders like heart attacks, Gaucher's diseases, and diabetics. Analysts at MarketDataForecast forecasted that these t factors driving significant growth in the market over the forecast period.  

Protein Therapeutics Market - By Therapeutic Modalities:

  • Protein Diagnostics
  • Protein Vaccines
  • Protein Therapeutics with Special Targeting Activity
  • Protein Therapeutics with Enzymatic Or Regulatory Activity

Protein Therapeutics Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographically, the North American market was the leader in the global protein therapeutics market in 2019. This trend is likely to continue in the forecast period. However, growing awareness about these novel treatment methods in the emerging economies makes it possible that Asia Pacific will grow with the highest CAGR in the forecast period.

Among all these regions, the North American region is accounting for a large regional market due to the rise of initiatives taken by the North American government and the rapid rise of safety and health concerns in healthcare professionals. Additionally, the increase in cancer prevalence is also a major booster of the protein therapeutics market. As per the National Cancer Institute, nearly 1,735,350 new cases were diagnosed in the US. North American region is contributing significant share due to the factors mentioned above.

The European region was registered as the second largest revenue region across the globe in 2019 due to developed countries such as Germany, France, Italy, and the UK in the European region. Moreover, the European region is owning factors such as increment of healthcare infrastructure and expenditure. Nowadays, increased cases of rheumatoid arthritis, chronic inflammatory demyelinating polyneuropathy, and multiple sclerosis result in the growth of the protein therapeutics market over the forecast period. As per the national Rheumatoid Arthritis Society report, nearly 4,00,000 patients were suffered from rheumatoid arthritis. These are the boosting factors of the European region in the forecast period.

Asia-Pacific region is accounting high and fast growth share in the protein therapeutics market. The Asia-Pacific region owns many advantageous factors, such as significant market key players and the increment of R&D's in the protein therapeutics market. Moreover, the rapid rise in government focus on vaccinations causes various diseases and a giant high population. Majorly Japanese government contributes a significant share by providing free hepatitis tests in 2020 between 40 and 70. In addition to that growth of the geriatric population in countries like China, Japan, and India. Countries like China, Japan, and India contribute a significant share in the Asia-Pacific region's protein therapeutics market.

The Middle East and Africa region is contributing share but least due to lack of advanced technology. However, the Middle East and Africa region own factors such as initiatives steps taken by the government in the healthcare sector of South Africa and the UAE. The factors mentioned above are drivers of the Middle East and Africa region.

KEY MARKET PARTICIPANTS:

Companies that are playing a promising role in the global protein therapeutics market profiled in this report are Baxter International Inc., Eli Lilly, and Company, Abbott Laboratories, Amgen Inc., F. Hoffmann-La Roche Ltd. Other players in the market are Novo Nordisk A/S, Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., and Sanofi.

1. Introduction                                

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods                          

               1.4 General Study Assumptions                 

2. Research Methodology                                          

               2.1 Introduction                             

               2.2 Research Phases                      

                              2.2.1 Secondary Research           

                              2.2.2 Primary Research 

                              2.2.3 Econometric Modelling      

                              2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline                         

3. Overview                                     

               3.1 Executive Summary                

               3.2 Key Inferences                         

               3.3 Epidemology                            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

               4.1 Market Drivers                         

               4.2 Market Restraints                   

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market               

5. Market Segmentation                                            

               5.1 Product                       

                              5.1.1 Introduction           

                              5.1.2 Monoclonal Antibodies      

                              5.1.3 Insulin       

                              5.1.4 Fusion Protein       

                              5.1.5 Erythropoietin       

                              5.1.6 Interferon

                              5.1.7 Human Growth Hormone  

                              5.1.8 Follicle Stimulating Hormone          

                              5.1.9 Y-o-Y Growth Analysis, By Product

                              5.1.10 Market Attractiveness Analysis, By Product           

                              5.1.11 Market Share Analysis, By Product            

               5.2 Therapeutic Modalities                         

                              5.2.1 Introduction           

                              5.2.2 Protein diagnostics             

                              5.2.3 Protein vaccines   

                              5.2.4 Protein therapeutics with special targeting activity

                              5.2.5 Protein therapeutics with enzymatic or regulatory activity 

                              5.2.6 Y-o-Y Growth Analysis, By Therapeutic Modalities  

                              5.2.7 Market Attractiveness Analysis, By Therapeutic Modalities

                              5.2.8 Market Share Analysis, By Therapeutic Modalities

               5.3 Application                 

                              5.3.1 Introduction           

                              5.3.2 Metabolic Disorders            

                              5.3.3 Immunologic Disorders      

                              5.3.4 Hematological Disorders    

                              5.3.5 Cancer      

                              5.3.6 Hormonal Disorders            

                              5.3.7 Genetic Disorders 

                              5.3.8 Others      

                              5.3.9 Y-o-Y Growth Analysis, By Application         

                              5.3.10 Market Attractiveness Analysis, By Application     

                              5.3.11 Market Share Analysis, By Application      

6. Geographical Analysis                                            

               6.1 Introduction                             

                              6.1.1 Regional Trends    

                              6.1.2 Impact Analysis     

                              6.1.3 Y-o-Y Growth Analysis        

                                             6.1.3.1 By Geographical Area

                                             6.1.3.2 By Product

                                             6.1.3.3 By Therapeutic Modalities

                                             6.1.3.4 By Application

                              6.1.4  Market Attractiveness Analysis      

                                             6.1.4.1 By Geographical Area

                                             6.1.4.2 By Product

                                             6.1.4.3 By Therapeutic Modalities

                                             6.1.4.4 By Application

                              6.1.5  Market Share Analysis       

                                             6.1.5.1 By Geographical Area

                                             6.1.5.2 By Product

                                             6.1.5.3 By Therapeutic Modalities

                                             6.1.5.4 By Application

               6.2 North America                         

                              6.1.1 Introduction           

                              6.1.2 United States         

                              6.1.3 Canada     

               6.3 Europe                        

                              6.2.1 Introduction           

                              6.2.2 U.K            

                              6.2.3 Spain         

                              6.2.4 Germany  

                              6.2.5 Italy           

                              6.2.6 France      

               6.4 Asia-Pacific                

                              6.3.1 Introduction           

                              6.3.2 China        

                              6.3.3 India         

                              6.3.4 Japan        

                              6.3.5 Australia   

                              6.3.6 South Korea           

               6.5 Latin America                           

                              6.4.1 Introduction           

                              6.4.2 Brazil         

                              6.4.3 Argentina 

                              6.4.4 Mexico     

                              6.4.5 Rest of Latin America          

               6.6 Middle East & Africa              

                              6.5.1 Introduction           

                              6.5.2 Middle-East           

                              6.5.3 Africa        

7. Strategic Analysis                                      

               7.1 PESTLE analysis                        

                              7.1.1 Political    

                              7.1.2 Economic 

                              7.1.3 Social        

                              7.1.4 Technological        

                              7.1.5 Legal         

                              7.1.6 Environmental       

               7.2 Porter’s Five analysis                             

                              7.2.1 Bargaining Power of Suppliers         

                              7.2.2 Bargaining Power of Consumers     

                              7.2.3 Threat of New Entrants      

                              7.2.4 Threat of Substitute Products and Services

                              7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                       

               8.1 Abbott Laboratories               

                              8.1.1 Overview 

                              8.1.2 Product Analysis   

                              8.1.3 Financial analysis  

                              8.1.4 Recent Developments        

                              8.1.5 SWOT analysis       

                              8.1.6 Analyst View          

               8.2 Amgen Inc.                

               8.3 Baxter International Inc.                      

               8.4 Eli Lilly and Company                            

               8.5 F. Hoffmann-La Roche Ltd.                  

               8.6 Johnson & Johnson                

               8.7 Merck & Co. Inc.                     

               8.8 Novo Nordisk A/S                    

               8.9 Pfizer Inc.                   

               8.10 Sanofi                       

9. Competitive Landscape                                         

               9.1 Market share analysis                           

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures                          

               9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                          

               a) List of Tables                

               b) List of Figures                             

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Protein Therapeutics Market, By Region, From 2020 to 2025 (USD Billion)
  2. Global Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  3. Global Monoclonal Antibodies Market, By Region, From 2020 to 2025 (USD Billion)
  4. Global Insulin Market, By Region, From 2020 to 2025 (USD Billion)
  5. Global Fusion Protein Market, By Region, From 2020 to 2025 (USD Billion)
  6. Global Erythropoietin Market, By Region, From 2020 to 2025 (USD Billion)
  7. Global Interferon Market, By Region, From 2020 to 2025 (USD Billion)
  8. Global Human Growth Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  9. Global Follicle Stimulating Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  10. Global Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  11. Global Metabolic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  12. Global Immunologic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  13. Global Hematological Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  14. Global Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  15. Global Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  16. Global Genetic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  17. Global Others Market, By Region, From 2020 to 2025 (USD Billion)
  18. Global Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  19. Global Protein diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  20. Global Protein vaccines Market, By Region, From 2020 to 2025 (USD Billion)
  21. Global Protein therapeutics with special targeting activity Market, By Region, From 2020 to 2025 (USD Billion)
  22. Global Protein therapeutics with enzymatic or regulatory activity Market, By Region, From 2020 to 2025 (USD Billion)
  23. North America Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  24. North America Monoclonal Antibodies Market, By Region, From 2020 to 2025 (USD Billion)
  25. North America Insulin Market, By Region, From 2020 to 2025 (USD Billion)
  26. North America Fusion Protein Market, By Region, From 2020 to 2025 (USD Billion)
  27. North America Erythropoietin Market, By Region, From 2020 to 2025 (USD Billion)
  28. North America Interferon Market, By Region, From 2020 to 2025 (USD Billion)
  29. North America Human Growth Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  30. North America Follicle Stimulating Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  31. North America Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  32. North America Metabolic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  33. North America Immunologic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  34. North America Hematological Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  35. North America Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  36. North America Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  37. North America Genetic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  38. North America Others Market, By Region, From 2020 to 2025 (USD Billion)
  39. North America Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  40. North America Protein diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  41. North America Protein vaccines Market, By Region, From 2020 to 2025 (USD Billion)
  42. North America Protein therapeutics with special targeting activity Market, By Region, From 2020 to 2025 (USD Billion)
  43. North America Protein therapeutics with enzymatic or regulatory activity Market, By Region, From 2020 to 2025 (USD Billion)
  44. United States Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  45. United States Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  46. United States Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  47. Canada Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  48. Canada Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  49. Canada Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  50. Europe Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  51. Europe Monoclonal Antibodies Market, By Region, From 2020 to 2025 (USD Billion)
  52. Europe Insulin Market, By Region, From 2020 to 2025 (USD Billion)
  53. Europe Fusion Protein Market, By Region, From 2020 to 2025 (USD Billion)
  54. Europe Erythropoietin Market, By Region, From 2020 to 2025 (USD Billion)
  55. Europe Interferon Market, By Region, From 2020 to 2025 (USD Billion)
  56. Europe Human Growth Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  57. Europe Follicle Stimulating Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  58. Europe Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  59. Europe Metabolic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  60. Europe Immunologic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  61. Europe Hematological Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  62. Europe Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  63. Europe Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  64. Europe Genetic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  65. Europe Others Market, By Region, From 2020 to 2025 (USD Billion)
  66. Europe Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  67. Europe Protein diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  68. Europe Protein vaccines Market, By Region, From 2020 to 2025 (USD Billion)
  69. Europe Protein therapeutics with special targeting activity Market, By Region, From 2020 to 2025 (USD Billion)
  70. Europe Protein therapeutics with enzymatic or regulatory activity Market, By Region, From 2020 to 2025 (USD Billion)
  71. U.K. Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  72. U.K. Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  73. U.K. Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  74. Germany Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  75. Germany Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  76. Germany Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  77. France Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  78. France Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  79. France Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  80. Italy Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  81. Italy Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  82. Italy Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  83. Spain Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  84. Spain Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  85. Spain Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  86. Asia Pacific Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  87. Asia Pacific Monoclonal Antibodies Market, By Region, From 2020 to 2025 (USD Billion)
  88. Asia Pacific Insulin Market, By Region, From 2020 to 2025 (USD Billion)
  89. Asia Pacific Fusion Protein Market, By Region, From 2020 to 2025 (USD Billion)
  90. Asia Pacific Erythropoietin Market, By Region, From 2020 to 2025 (USD Billion)
  91. Asia Pacific Interferon Market, By Region, From 2020 to 2025 (USD Billion)
  92. Asia Pacific Human Growth Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  93. Asia Pacific Follicle Stimulating Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  94. Asia Pacific Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  95. Asia Pacific Metabolic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  96. Asia Pacific Immunologic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  97. Asia Pacific Hematological Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  98. Asia Pacific Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  99. Asia Pacific Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  100. Asia Pacific Genetic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  101. Asia Pacific Others Market, By Region, From 2020 to 2025 (USD Billion)
  102. Asia Pacific Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  103. Asia Pacific Protein diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  104. Asia Pacific Protein vaccines Market, By Region, From 2020 to 2025 (USD Billion)
  105. Asia Pacific Protein therapeutics with special targeting activity Market, By Region, From 2020 to 2025 (USD Billion)
  106. Asia Pacific Protein therapeutics with enzymatic or regulatory activity Market, By Region, From 2020 to 2025 (USD Billion)
  107. Japan Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  108. Japan Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  109. Japan Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  110. China Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  111. China Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  112. China Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  113. India Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  114. India Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  115. India Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  116. Australia Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  117. Australia Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  118. Australia Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  119. South Korea Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  120. South Korea Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  121. South Korea Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  122. Latin America Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  123. Latin America Monoclonal Antibodies Market, By Region, From 2020 to 2025 (USD Billion)
  124. Latin America Insulin Market, By Region, From 2020 to 2025 (USD Billion)
  125. Latin America Fusion Protein Market, By Region, From 2020 to 2025 (USD Billion)
  126. Latin America Erythropoietin Market, By Region, From 2020 to 2025 (USD Billion)
  127. Latin America Interferon Market, By Region, From 2020 to 2025 (USD Billion)
  128. Latin America Human Growth Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  129. Latin America Follicle Stimulating Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  130. Latin America Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  131. Latin America Metabolic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  132. Latin America Immunologic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  133. Latin America Hematological Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  134. Latin America Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  135. Latin America Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  136. Latin America Genetic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  137. Latin America Others Market, By Region, From 2020 to 2025 (USD Billion)
  138. Latin America Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  139. Latin America Protein diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  140. Latin America Protein vaccines Market, By Region, From 2020 to 2025 (USD Billion)
  141. Latin America Protein therapeutics with special targeting activity Market, By Region, From 2020 to 2025 (USD Billion)
  142. Latin America Protein therapeutics with enzymatic or regulatory activity Market, By Region, From 2020 to 2025 (USD Billion)
  143. Brazil Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  144. Brazil Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  145. Brazil Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  146. Argentina Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  147. Argentina Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  148. Argentina Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  149. Mexico Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  150. Mexico Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  151. Mexico Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  152. Rest of Latin America Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  153. Rest of Latin America Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  154. Rest of Latin America Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  155. Middle East and Africa Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  156. Middle East and Africa Monoclonal Antibodies Market, By Region, From 2020 to 2025 (USD Billion)
  157. Middle East and Africa Insulin Market, By Region, From 2020 to 2025 (USD Billion)
  158. Middle East and Africa Fusion Protein Market, By Region, From 2020 to 2025 (USD Billion)
  159. Middle East and Africa Erythropoietin Market, By Region, From 2020 to 2025 (USD Billion)
  160. Middle East and Africa Interferon Market, By Region, From 2020 to 2025 (USD Billion)
  161. Middle East and Africa Human Growth Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  162. Middle East and Africa Follicle Stimulating Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  163. Middle East and Africa Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  164. Middle East and Africa Metabolic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  165. Middle East and Africa Immunologic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  166. Middle East and Africa Hematological Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  167. Middle East and Africa Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  168. Middle East and Africa Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  169. Middle East and Africa Genetic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  170. Middle East and Africa Others Market, By Region, From 2020 to 2025 (USD Billion)
  171. Middle East and Africa Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  172. Middle East and Africa Protein diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  173. Middle East and Africa Protein vaccines Market, By Region, From 2020 to 2025 (USD Billion)
  174. Middle East and Africa Protein therapeutics with special targeting activity Market, By Region, From 2020 to 2025 (USD Billion)
  175. Middle East and Africa Protein therapeutics with enzymatic or regulatory activity Market, By Region, From 2020 to 2025 (USD Billion)
  176. Middle East Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  177. Middle East Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  178. Middle East Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  179. Africa Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  180. Africa Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  181. Africa Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample